Literature DB >> 33070305

Physician trajectories of abandoning long-course breast radiotherapy and their cost impact.

Xiao Xu1,2, Pamela R Soulos2,3, Jeph Herrin2,4, Shi-Yi Wang2,5, Craig Evan Pollack6,7, Suzanne B Evans8, James B Yu2,8, Cary P Gross2,3.   

Abstract

OBJECTIVE: To examine variation in trajectories of abandoning conventionally fractionated whole-breast irradiation (CF-WBI) for adjuvant breast radiotherapy among physician peer groups and the associated cost implications. DATA SOURCES: Medicare claims data were obtained from the Chronic Conditions Data Warehouse for fee-for-service beneficiaries with breast cancer in 2011-2014. STUDY
DESIGN: We used social network methods to identify peer groups of physicians that shared patients. For each physician peer group in each time period (T1 = 2011-2012 and T2 = 2013-2014), we calculated a risk-adjusted rate of CF-WBI use among eligible women, after adjusting for patient clinical characteristics. We applied a latent class growth analysis to these risk-adjusted rates to identify distinct trajectories of CF-WBI use among physician peer groups. We further estimated potential savings to the Medicare program by accelerating abandonment of CF-WBI in T2 using a simulation model. DATA COLLECTION/EXTRACTION
METHODS: Use of conventionally fractionated whole-breast irradiation was determined from Medicare claims among women ≥ 66 years of age who underwent adjuvant radiotherapy after breast conserving surgery. PRINCIPAL
FINDINGS: Among 215 physician peer groups caring for 16 988 patients, there were four distinct trajectories of abandoning CF-WBI: (a) persistent high use (mean risk-adjusted utilization rate: T1 = 94.3%, T2 = 90.6%); (b) decreased high use (T1 = 81.3%, T2 = 65.3%); (c) decreased medium use (T1 = 60.1%, T2 = 44.0%); and (d) decreased low use (T1 = 31.6%, T2 = 23.6%). Peer groups with a smaller proportion of patients treated at free-standing radiation facilities and a larger proportion of physicians that were surgeons tended to follow trajectories with lower use of CF-WBI. If all physician peer groups had practice patterns in T2 similar to those in the "decreased low use" trajectory, the Medicare program could save $83.3 million (95% confidence interval: $58.5 million-$112.2 million).
CONCLUSIONS: Physician peer groups had distinct trajectories of abandoning CF-WBI. Physician composition and setting of radiotherapy were associated with the different trajectories. Distinct practice patterns across the trajectories had important cost implications. © Health Research and Educational Trust.

Entities:  

Keywords:  abandonment; breast cancer; conventionally fractionated; hypofractionated; physician peer group; radiotherapy; trajectory

Mesh:

Year:  2020        PMID: 33070305      PMCID: PMC8143683          DOI: 10.1111/1475-6773.13572

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.734


  38 in total

1.  Patterns and correlates of adjuvant radiotherapy receipt after lumpectomy and after mastectomy for breast cancer.

Authors:  Reshma Jagsi; Paul Abrahamse; Monica Morrow; Sarah T Hawley; Jennifer J Griggs; John J Graff; Ann S Hamilton; Steven J Katz
Journal:  J Clin Oncol       Date:  2010-03-29       Impact factor: 44.544

Review 2.  Contemporary Guidelines in Whole-Breast Irradiation: An Alternative Perspective.

Authors:  Abram Recht; Heather McArthur; Lawrence J Solin; Rahul Tendulkar; Alexander Whitley; Armando Giuliano
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-10-23       Impact factor: 7.038

3.  Projections of the cost of cancer care in the United States: 2010-2020.

Authors:  Angela B Mariotto; K Robin Yabroff; Yongwu Shao; Eric J Feuer; Martin L Brown
Journal:  J Natl Cancer Inst       Date:  2011-01-12       Impact factor: 13.506

4.  Cost Implications of an Evidence-Based Approach to Radiation Treatment After Lumpectomy for Early-Stage Breast Cancer.

Authors:  Rachel A Greenup; Rachel C Blitzblau; Kevin L Houck; Julie Ann Sosa; Janet Horton; Jeffrey M Peppercorn; Alphonse G Taghian; Barbara L Smith; E Shelley Hwang
Journal:  J Oncol Pract       Date:  2017-03-14       Impact factor: 3.840

5.  Utilization trend and regimens of hypofractionated whole breast radiation therapy in the United States.

Authors:  Yasmin Hasan; Joseph Waller; Katharine Yao; Steven J Chmura; Dezheng Huo
Journal:  Breast Cancer Res Treat       Date:  2017-01-24       Impact factor: 4.872

Review 6.  Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline.

Authors:  Benjamin D Smith; Soren M Bentzen; Candace R Correa; Carol A Hahn; Patricia H Hardenbergh; Geoffrey S Ibbott; Beryl McCormick; Julie R McQueen; Lori J Pierce; Simon N Powell; Abram Recht; Alphonse G Taghian; Frank A Vicini; Julia R White; Bruce G Haffty
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-07-16       Impact factor: 7.038

7.  Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial.

Authors:  Simona F Shaitelman; Pamela J Schlembach; Isidora Arzu; Matthew Ballo; Elizabeth S Bloom; Daniel Buchholz; Gregory M Chronowski; Tomas Dvorak; Emily Grade; Karen E Hoffman; Patrick Kelly; Michelle Ludwig; George H Perkins; Valerie Reed; Shalin Shah; Michael C Stauder; Eric A Strom; Welela Tereffe; Wendy A Woodward; Joe Ensor; Donald Baumann; Alastair M Thompson; Diana Amaya; Tanisha Davis; William Guerra; Lois Hamblin; Gabriel Hortobagyi; Kelly K Hunt; Thomas A Buchholz; Benjamin D Smith
Journal:  JAMA Oncol       Date:  2015-10       Impact factor: 31.777

8.  Physician peer group characteristics and timeliness of breast cancer surgery.

Authors:  Jacqueline Bachand; Pamela R Soulos; Jeph Herrin; Craig E Pollack; Xiao Xu; Xiaomei Ma; Cary P Gross
Journal:  Breast Cancer Res Treat       Date:  2018-04-24       Impact factor: 4.872

9.  The adoption of new adjuvant radiation therapy modalities among Medicare beneficiaries with breast cancer: clinical correlates and cost implications.

Authors:  Kenneth B Roberts; Pamela R Soulos; Jeph Herrin; James B Yu; Jessica B Long; Edward Dostaler; Cary P Gross
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-11-20       Impact factor: 7.038

10.  Enhancing the role of case-oriented peer review to improve quality and safety in radiation oncology: Executive summary.

Authors:  Lawrence B Marks; Robert D Adams; Todd Pawlicki; Albert L Blumberg; David Hoopes; Michael D Brundage; Benedick A Fraass
Journal:  Pract Radiat Oncol       Date:  2013-03-16
View more
  1 in total

1.  Physician trajectories of abandoning long-course breast radiotherapy and their cost impact.

Authors:  Xiao Xu; Pamela R Soulos; Jeph Herrin; Shi-Yi Wang; Craig Evan Pollack; Suzanne B Evans; James B Yu; Cary P Gross
Journal:  Health Serv Res       Date:  2020-10-18       Impact factor: 3.734

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.